We often don’t know the damaging effects of new drugs until well after the fact, unfortunately. That’s why there are so many class action lawsuits against drugmakers. Here’s what got Onglyza on the FDA’s radar for causing heart problems in patients.
A woman took Onglyza for Type 2 diabetes in 2010. In 2011, she suffered a heart failure and then was hospitalized twice more in before her death in 2013. The woman sued AstraZeneca in response. During this time, the FDA was running a large study to see if there was a link between Onglyza and heart failure. The 16,000 patients who took the drug saw a 27% increase in heart failure! With this evidence, the daughter of the dead woman is requesting a trial by jury and damages of around $50,000.
This is just the tip of the iceberg though. Further claims are coming to light about the drugs causing increases in pancreatic inflammation and even pancreatic cancer. There are many lawsuits related to this side effect as well and the courts are having difficulty processing them due to the sheer quantity.
This drug appears to be very dangerous from all the evidence. If you believe that you or a loved one has suffered heart problems, pancreatic issues, or any of the other symptoms listed at the top of the page from taking Onglyza or another DPP-4 inhibitor, contact John Foy & Associates to see how you can get representation in court for your injuries.